CLINICAL_TRIALS
trial_result
· 2024-04-16
Clinical Trial Update: A Study of Guselkumab in Participants With Active Lupus Nephritis [Phase 2]
Summary
Phase 2 study evaluating guselkumab for active lupus nephritis was terminated, with results posted in 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Research & Development, LLC | Conditions: Lupus Nephritis | Phase 2 | Status: TERMINATED | Results posted: 2024-04-16